Tiffany Tolmie | Manager, Investor Relations |
Mark Murray | Chief Executive Officer |
Mike Sofia | Chief Scientific Officer |
Bill Symonds | Chief Development Officer |
Koert VandenEnden | Interim CFO |
Katherine Xu | William Blair |
Michael Yee | Jefferies |
David Martin | Bloom Burton |
Lisa Bayko | JMP Securities |
Madhu Kumar | B. Riley FBR |
Good day, ladies and gentlemen, and welcome to the Arbutus Biopharma Fourth Quarter and Year-End 2017 Financial Results and Corporate Update. At this time all participants are in a listen only mode. Later we'll conduct a question-and-answer session and instruction will follow at that time.
As a reminder, this conference is being recorded. I would now like to hand the floor over to Tiffany Tolmie, Manager of Investor Relations.